Items where Author is "Bargetzi, M."

2015

Rast, A. C. and Kutz, A. and Felder, S. and Faessler, L. and Steiner, D. and Laukemann, S. and Haubitz, S. and Huber, A. and Buergi, U. and Conca, A. and Reutlinger, B. and Mueller, B. and Bargetzi, M. and Schuetz, P.. (2015) Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study. Disease Markers, 2015. p. 795801.

2011

Häne, A. and Bargetzi, M. and Hewer, E. and Bruehlmeier, M. and Khamis, A. and Roelcke, U.. (2011) Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour. Journal of neurology, Vol. 258, H. 2. pp. 318-320.

Kuenzler, A. and Hodgkinson, K. and Zindel, A. and Bargetzi, M. and Znoj, H. J.. (2011) Who cares, who bears, who benefits? Female spouses vicariously carry the burden after cancer diagnosis. Psychology & health, Vol. 26, H. 3. pp. 337-352.

2010

Taverna, C. and Bargetzi, M. and Betticher, D. and Gmür, J. and Gregor, M. and Heim, D. and Hess, U. and Ketterer, N. and Lerch, E. and Matthes, T. and Mey, U. and Pabst, T. and Renner, C.. (2010) Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations. Swiss Medical Weekly, Vol. 140 , w13054.

Künzler, A. and Zindel, A. and Znoj, H. J. and Bargetzi, M.. (2010) [Distress among cancer patients and their partners in the first year after diagnosis]. Schweizerische Rundschau für Medizin Praxis, Vol. 99, H. 10. pp. 593-599.

2009

Zenhäusern, R. and Schmitz, S.-F Hsu and Solenthaler, M. and Heim, D. and Meyer-Monard, S. and Hess, U. and Leoncini, L. and Bargetzi, M. and Rufener, B. and Tobler, A.. (2009) Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia : a multicenter phase III trial (SAKK 32/98). Leukemia [and] lymphoma, Vol. 50. pp. 1501-1511.

2008

Röthlisberger, B. and Huber, A. and Bargetzi, M. and Mendez, A. and Heizmann, M.. (2008) JAK2 exon 12 mutation in JAK2V617F-negative polycythemia vera. Leukemia & lymphoma, Vol. 49. pp. 586-588.

Zenhäusern, R. and Simcock, M. and Gratwohl, A. and Hess, U. and Bargetzi, M. and Tobler, A. and Swiss, Group for Clinical Cancer Research. (2008) Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98). Haematologica, Vol. 93, H. 9. pp. 1426-1428.